JHL Biotech is proud to present our very own sponsored event called the 2020 Biopharma Summit, bringing together a vast panel of speakers and panelists within the Taiwan Biotechnology & Manufacturing Industry. Please join us as one of the hundreds of attendees who are interested in learning about the industry and hearing shared experiences from Taiwan’s top Scientific and Biotech/Pharmaceutical brass about the future growth and plans for international exposure. (Summit will be conducted in Chinese.)
About JHL Biotech
JHL is a biopharmaceutical company established in 2012 and after a transformation under new executive leadership led by James Huang, Chairman and CEO (also Managing Director of KPCB China), JHL continues to focus on three biotech sectors: 1) Accelerating the development programs for clients through the provision of Contract Development and Manufacturing Services (from cell line development to commercial manufacturing with regulatory filing support; 2) Developing a Proprietary Biosimilar Pipeline; and 3) Collaborating & Licensing of New and Innovative Biologics.
For more information, please contact JHL at firstname.lastname@example.org